162 assets in Mantle Cell Lymphoma

Therapeutic assets addressing Mantle Cell Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tcm-Enriched T Cells Mantle Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes Mantle Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Egfrt/19-28Z/Il-12 Car T-Lymphocytes Mantle Cell Lymphoma	Roswell Park Cancer Institute	P1	CC (43)
Hmpl-760 Mantle Cell Lymphoma	Hutchmed	P1	CC (43)
Loxo-338 Mantle Cell Lymphoma	Eli Lilly and Company	P1	CC (43)
ly4152199 - iv Mantle Cell Lymphoma	Eli Lilly and Company	P1	CC (43)
pep07 Mantle Cell Lymphoma	PharmaEngine	P1	CC (43)
Pevonedistat Mantle Cell Lymphoma	City of Hope Medical Center	P1	CC (43)
Bgb-16673 Mantle Cell Lymphoma	BeiGene	P1/2	CC (41)
bn301 Mantle Cell Lymphoma	BioNova Pharmaceuticals (Shanghai) LTD.	P1/2	CC (41)
Btk-In-24 Mantle Cell Lymphoma	Nurix Therapeutics, Inc.	P1	CC (41)
Car-Nk-Cd19 Cells Mantle Cell Lymphoma	Second Affiliated Hospital, School of Medicine, Zhejiang University	P1	CC (41)
ctx112 Mantle Cell Lymphoma	CRISPR Therapeutics AG	P1/2	CC (41)
Cytokine-Treated Veto Cells Mantle Cell Lymphoma	M.D. Anderson Cancer Center	P1/2	CC (41)
exs73565 Mantle Cell Lymphoma	Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.	P1	CC (41)
Fctx-Cl19-1 Mantle Cell Lymphoma	FamiCordTx	P1	CC (41)
Jwcar239 Mantle Cell Lymphoma	Peking University Cancer Hospital & Institute	P1	CC (41)
Ltz-301 Mantle Cell Lymphoma	LTZ Therapeutics, Inc.	P1	CC (41)
tqb3909 Mantle Cell Lymphoma	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	P1/2	CC (41)
Vnx-101 Mantle Cell Lymphoma	Vironexis Biotherapeutics Inc.	P1/2	CC (41)
Wztl002-1 Mantle Cell Lymphoma	Malaghan Institute of Medical Research	P1	CC (41)
xl114 Mantle Cell Lymphoma	Exelixis	P1	CC (41)
Zelebrudomide Mantle Cell Lymphoma	Nurix Therapeutics, Inc.	P1	CC (41)
Azacitidine Mantle Cell Lymphoma	Prelude Therapeutics	P1	CC (40)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor Mantle Cell Lymphoma	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	P1	CC (40)
lp-168 Mantle Cell Lymphoma	Guangzhou Lupeng Pharmaceutical Company LTD.	P1	CC (40)
Prgn-3007 Mantle Cell Lymphoma	H. Lee Moffitt Cancer Center and Research Institute	P1	CC (40)
Anti-Cd19-Car Cmv-Specific T-Lymphocytes Mantle Cell Lymphoma	City of Hope Medical Center	P1	C (37)
BP1002 Mantle Cell Lymphoma	Bio-Path Holdings, Inc.	P1	C (37)
Car.K.28 Mantle Cell Lymphoma	UNC Lineberger Comprehensive Cancer Center	P1	C (37)
cd19.20.22 car t cells Mantle Cell Lymphoma	University of Maryland, Baltimore	P1	C (37)
cd22 car-t Mantle Cell Lymphoma	Stanford University	P1	C (37)
cd79b-19 car t cells Mantle Cell Lymphoma	Marcela V. Maus, M.D.,Ph.D.	P1	C (37)
Clic-2201 Mantle Cell Lymphoma	British Columbia Cancer Agency	P1	C (37)
Docirbrutinib Mantle Cell Lymphoma	Carna Biosciences, Inc.	P1	C (37)
iks03 Mantle Cell Lymphoma	Iksuda Therapeutics Ltd.	P1	C (37)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Mantle Cell Lymphoma	OncoNano Medicine, Inc.	P1	C (37)
lv20.19 car t cells Mantle Cell Lymphoma	Medical College of Wisconsin	P1	C (37)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine Mantle Cell Lymphoma	City of Hope Medical Center	P1	C (37)
nkx019 Mantle Cell Lymphoma	Nkarta, Inc.	P1	C (37)
Onm-501 Mantle Cell Lymphoma	OncoNano Medicine, Inc.	P1	C (37)
PRT1419 Mantle Cell Lymphoma	Prelude Therapeutics	P1	C (37)
psb202 Mantle Cell Lymphoma	Qilu Puget Sound Biotherapeutics (dba Sound Biologics)	P1	C (37)
Sgr-1505 Mantle Cell Lymphoma	Schrödinger, Inc.	P1	C (37)
Stk-009 Mantle Cell Lymphoma	Synthekine	P1	C (37)
Syncar-001 Mantle Cell Lymphoma	Synthekine	P1	C (37)
Synkir-310 Mantle Cell Lymphoma	Verismo Therapeutics	P1	C (37)
Allogeneic Natural Killer Cells Mantle Cell Lymphoma	Paolo Caimi, MD	P1	C (35)
ft596 Mantle Cell Lymphoma	Fate Therapeutics	P1	C (35)
rd14-01 cell Mantle Cell Lymphoma	He Huang	Early P1	C (34)

Showing 101 to 150 of 162 assets

PreviousPage 3 of 4Next